Real Estate - Development
Compare Stocks
5 / 10Stock Comparison
AXR vs ALCO vs STRR vs JBSS vs CODI
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Farm Products
Medical - Diagnostics & Research
Packaged Foods
Conglomerates
AXR vs ALCO vs STRR vs JBSS vs CODI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Real Estate - Development | Agricultural Farm Products | Medical - Diagnostics & Research | Packaged Foods | Conglomerates |
| Market Cap | $142M | $316M | $29M | $913M | $905M |
| Revenue (TTM) | $53M | $29M | $114M | $1.14B | $1.85B |
| Net Income (TTM) | $13M | $-142M | $-6M | $70M | $-227M |
| Gross Margin | 73.5% | -6.0% | 40.9% | 19.1% | 38.7% |
| Operating Margin | 26.1% | -7.5% | -1.0% | 8.9% | 0.3% |
| Forward P/E | 12.7x | — | — | 10.7x | 150.4x |
| Total Debt | $68K | $86M | $1M | $102M | $1.88B |
| Cash & Equiv. | $40M | $38M | $17M | $585K | $68M |
AXR vs ALCO vs STRR vs JBSS vs CODI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMREP Corporation (AXR) | 100 | 636.1 | +536.1% |
| Alico, Inc. (ALCO) | 100 | 128.7 | +28.7% |
| Star Equity Holding… (STRR) | 100 | 106.8 | +6.8% |
| John B. Sanfilippo … (JBSS) | 100 | 89.8 | -10.2% |
| Compass Diversified (CODI) | 100 | 70.9 | -29.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AXR vs ALCO vs STRR vs JBSS vs CODI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AXR ranks third and is worth considering specifically for long-term compounding.
- 5.0% 10Y total return vs JBSS's 101.1%
- 24.4% margin vs ALCO's -487.4%
ALCO is the clearest fit if your priority is momentum.
- +42.5% vs CODI's -30.3%
STRR has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.19, yield 7.0%
- Lower volatility, beta 0.19, Low D/E 2.6%, current ratio 3.58x
- Beta 0.19, yield 7.0%, current ratio 3.58x
- Beta 0.19 vs CODI's 1.09, lower leverage
JBSS is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 3.8%, EPS growth -2.3%, 3Y rev CAGR 5.0%
- Lower P/E (10.7x vs 150.4x)
- 11.7% ROA vs ALCO's -72.7%, ROIC 15.2% vs -59.5%
CODI is the clearest fit if your priority is growth.
- 4.8% revenue growth vs STRR's -66.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.8% revenue growth vs STRR's -66.9% | |
| Value | Lower P/E (10.7x vs 150.4x) | |
| Quality / Margins | 24.4% margin vs ALCO's -487.4% | |
| Stability / Safety | Beta 0.19 vs CODI's 1.09, lower leverage | |
| Dividends | 7.0% yield, 1-year raise streak, vs ALCO's 0.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +42.5% vs CODI's -30.3% | |
| Efficiency (ROA) | 11.7% ROA vs ALCO's -72.7%, ROIC 15.2% vs -59.5% |
AXR vs ALCO vs STRR vs JBSS vs CODI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AXR vs ALCO vs STRR vs JBSS vs CODI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AXR leads in 2 of 6 categories
JBSS leads 1 • STRR leads 1 • ALCO leads 0 • CODI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AXR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CODI is the larger business by revenue, generating $1.8B annually — 63.5x ALCO's $29M. AXR is the more profitable business, keeping 24.4% of every revenue dollar as net income compared to ALCO's -4.9%. On growth, STRR holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $53M | $29M | $114M | $1.1B | $1.8B |
| EBITDAEarnings before interest/tax | $14M | -$41M | $2M | $127M | $109M |
| Net IncomeAfter-tax profit | $13M | -$142M | -$6M | $70M | -$227M |
| Free Cash FlowCash after capex | $14M | $19M | -$10M | $33M | $10M |
| Gross MarginGross profit ÷ Revenue | +73.5% | -6.0% | +40.9% | +19.1% | +38.7% |
| Operating MarginEBIT ÷ Revenue | +26.1% | -7.5% | -1.0% | +8.9% | +0.3% |
| Net MarginNet income ÷ Revenue | +24.4% | -4.9% | -5.4% | +6.2% | -12.3% |
| FCF MarginFCF ÷ Revenue | +25.7% | +66.3% | -8.4% | +2.9% | +0.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +93.8% | -88.8% | +2.5% | +4.6% | -5.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.5% | +62.5% | +28.2% | +31.9% | -5.1% |
Valuation Metrics
Evenly matched — AXR and CODI each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 11.3x trailing earnings, AXR trades at a 27% valuation discount to JBSS's 15.5x P/E. On an enterprise value basis, AXR's 8.3x EV/EBITDA is more attractive than CODI's 15.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $142M | $316M | $29M | $913M | $905M |
| Enterprise ValueMkt cap + debt − cash | $102M | $364M | $13M | $1.0B | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | 11.30x | -2.14x | -2.33x | 15.53x | -3.94x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.69x | — | — | 10.68x | 150.38x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 11.02x | — |
| EV / EBITDAEnterprise value multiple | 8.32x | — | — | 8.73x | 14.99x |
| Price / SalesMarket cap ÷ Revenue | 2.86x | 7.18x | 0.55x | 0.82x | 0.48x |
| Price / BookPrice ÷ Book value/share | 1.11x | 2.92x | 0.72x | 2.54x | 1.58x |
| Price / FCFMarket cap ÷ FCF | 14.71x | 21.63x | — | — | — |
Profitability & Efficiency
JBSS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JBSS delivers a 19.5% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-136 for ALCO. AXR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CODI's 3.27x. On the Piotroski fundamental quality scale (0–9), AXR scores 5/9 vs JBSS's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.6% | -135.6% | -13.0% | +19.5% | -49.6% |
| ROA (TTM)Return on assets | +10.5% | -72.7% | -8.7% | +11.7% | -7.3% |
| ROICReturn on invested capital | +10.2% | -59.5% | -24.3% | +15.2% | +1.0% |
| ROCEReturn on capital employed | +9.8% | -68.0% | -18.5% | +20.4% | +2.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 3 | 2 | 5 |
| Debt / EquityFinancial leverage | 0.00x | 0.79x | 0.03x | 0.28x | 3.27x |
| Net DebtTotal debt minus cash | -$40M | -$35M | -$16M | $102M | $1.8B |
| Cash & Equiv.Liquid assets | $40M | $38M | $17M | $585,000 | $68M |
| Total DebtShort + long-term debt | $68,000 | $86M | $1M | $102M | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | — | -57.14x | -47.19x | 26.02x | -0.97x |
Total Returns (Dividends Reinvested)
AXR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AXR five years ago would be worth $24,126 today (with dividends reinvested), compared to $4,995 for STRR. Over the past 12 months, ALCO leads with a +42.5% total return vs CODI's -30.3%. The 3-year compound annual growth rate (CAGR) favors AXR at 23.9% vs STRR's -25.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +40.1% | +12.7% | -13.3% | +14.1% | +158.7% |
| 1-Year ReturnPast 12 months | +23.8% | +42.5% | -7.0% | +39.3% | -30.3% |
| 3-Year ReturnCumulative with dividends | +90.3% | +82.3% | -58.8% | -22.9% | -25.6% |
| 5-Year ReturnCumulative with dividends | +141.3% | +45.6% | -50.1% | +4.0% | -35.5% |
| 10-Year ReturnCumulative with dividends | +504.5% | +66.6% | +50.6% | +101.1% | +53.7% |
| CAGR (3Y)Annualised 3-year return | +23.9% | +22.1% | -25.6% | -8.3% | -9.4% |
Risk & Volatility
Evenly matched — AXR and STRR each lead in 1 of 2 comparable metrics.
Risk & Volatility
STRR is the less volatile stock with a 0.19 beta — it tends to amplify market swings less than CODI's 1.09 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AXR currently trades 92.3% from its 52-week high vs CODI's 68.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.02x | 0.34x | 0.19x | 0.31x | 1.09x |
| 52-Week HighHighest price in past year | $29.00 | $44.86 | $11.99 | $85.15 | $17.46 |
| 52-Week LowLowest price in past year | $17.61 | $28.90 | $1.99 | $58.47 | $4.58 |
| % of 52W HighCurrent price vs 52-week peak | +92.3% | +92.1% | +77.1% | +91.7% | +68.9% |
| RSI (14)Momentum oscillator 0–100 | 48.0 | 44.6 | 44.6 | 49.2 | 70.0 |
| Avg Volume (50D)Average daily shares traded | 12K | 29K | 7K | 80K | 1.2M |
Analyst Outlook
STRR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AXR as "Buy", ALCO as "Buy", JBSS as "Buy", CODI as "Hold". Consensus price targets imply 24.7% upside for CODI (target: $15) vs 9.0% for ALCO (target: $45). For income investors, STRR offers the higher dividend yield at 7.01% vs ALCO's 0.48%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | Buy | Hold |
| Price TargetConsensus 12-month target | — | $45.00 | — | — | $15.00 |
| # AnalystsCovering analysts | 1 | 3 | — | 2 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +0.5% | +7.0% | +2.7% | +4.2% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $0.20 | $0.65 | $2.08 | $0.50 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.0% | +0.1% | +0.0% |
AXR leads in 2 of 6 categories (Income & Cash Flow, Total Returns). JBSS leads in 1 (Profitability & Efficiency). 2 tied.
AXR vs ALCO vs STRR vs JBSS vs CODI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AXR or ALCO or STRR or JBSS or CODI a better buy right now?
For growth investors, Compass Diversified (CODI) is the stronger pick with 4.
8% revenue growth year-over-year, versus -66. 9% for Star Equity Holdings, Inc. (STRR). AMREP Corporation (AXR) offers the better valuation at 11. 3x trailing P/E (12. 7x forward), making it the more compelling value choice. Analysts rate AMREP Corporation (AXR) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AXR or ALCO or STRR or JBSS or CODI?
On trailing P/E, AMREP Corporation (AXR) is the cheapest at 11.
3x versus John B. Sanfilippo & Son, Inc. at 15. 5x. On forward P/E, John B. Sanfilippo & Son, Inc. is actually cheaper at 10. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AXR or ALCO or STRR or JBSS or CODI?
Over the past 5 years, AMREP Corporation (AXR) delivered a total return of +141.
3%, compared to -50. 1% for Star Equity Holdings, Inc. (STRR). Over 10 years, the gap is even starker: AXR returned +504. 5% versus STRR's +50. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AXR or ALCO or STRR or JBSS or CODI?
By beta (market sensitivity over 5 years), Star Equity Holdings, Inc.
(STRR) is the lower-risk stock at 0. 19β versus Compass Diversified's 1. 09β — meaning CODI is approximately 467% more volatile than STRR relative to the S&P 500. On balance sheet safety, AMREP Corporation (AXR) carries a lower debt/equity ratio of 0% versus 3% for Compass Diversified — giving it more financial flexibility in a downturn.
05Which is growing faster — AXR or ALCO or STRR or JBSS or CODI?
By revenue growth (latest reported year), Compass Diversified (CODI) is pulling ahead at 4.
8% versus -66. 9% for Star Equity Holdings, Inc. (STRR). On earnings-per-share growth, the picture is similar: AMREP Corporation grew EPS 89. 6% year-over-year, compared to -22. 2% for Alico, Inc.. Over a 3-year CAGR, JBSS leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AXR or ALCO or STRR or JBSS or CODI?
AMREP Corporation (AXR) is the more profitable company, earning 25.
6% net margin versus -334. 3% for Alico, Inc. — meaning it keeps 25. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AXR leads at 24. 4% versus -450. 5% for ALCO. At the gross margin level — before operating expenses — AXR leads at 66. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AXR or ALCO or STRR or JBSS or CODI more undervalued right now?
On forward earnings alone, John B.
Sanfilippo & Son, Inc. (JBSS) trades at 10. 7x forward P/E versus 150. 4x for Compass Diversified — 139. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CODI: 24. 7% to $15. 00.
08Which pays a better dividend — AXR or ALCO or STRR or JBSS or CODI?
In this comparison, STRR (7.
0% yield), CODI (4. 2% yield), JBSS (2. 7% yield), ALCO (0. 5% yield) pay a dividend. AXR does not pay a meaningful dividend and should not be held primarily for income.
09Is AXR or ALCO or STRR or JBSS or CODI better for a retirement portfolio?
For long-horizon retirement investors, Star Equity Holdings, Inc.
(STRR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 19), 7. 0% yield). Both have compounded well over 10 years (STRR: +50. 6%, AXR: +504. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AXR and ALCO and STRR and JBSS and CODI?
These companies operate in different sectors (AXR (Real Estate) and ALCO (Consumer Defensive) and STRR (Healthcare) and JBSS (Consumer Defensive) and CODI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AXR is a small-cap deep-value stock; ALCO is a small-cap quality compounder stock; STRR is a small-cap income-oriented stock; JBSS is a small-cap deep-value stock; CODI is a small-cap income-oriented stock. STRR, JBSS, CODI pay a dividend while AXR, ALCO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.